Navigation Links
Mylan Launches Generic Version of Percodan® Tablets
Date:5/5/2011

PITTSBURGH, May 5, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals. This product is the generic version of Endo Pharmaceuticals' Percodan® Tablets, a treatment for moderate to severe pain.

Oxycodone and Aspirin Tablets had U.S. sales of approximately $6.5 million for the 12 months ending Dec. 31, 2010, according to IMS Health.

Currently, Mylan has 169 ANDAs pending FDA approval representing $100.7 billion in annual sales, according to IMS Health. Forty-five of these pending ANDAs are potential first-to-file opportunities, representing $25.8 billion in annual brand sales, for the 12 months ending June 30, 2010, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Mylan Schedules First Quarter 2011 Financial Results Conference Call and Live Webcast
2. Mylan Launches Generic Version of Sandostatin®
3. Mylans Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
4. Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year
5. Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions
6. Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
7. Mark W. Parrish Joins Mylans Board of Directors
8. WHO Withdraws Notice of Concern for Mylans Matrix Unit
9. Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
10. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
11. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... lawsuit against Genewiz Inc. in excess of $10 million. ... GenScript’s trade secrets, and that it improperly hired one ... an order denying motions for judgment notwithstanding the verdict, ...
(Date:2/26/2015)... -- BioEnterprise today announced that Northeast Ohio ... billion in growth funding during the past 13 years.  ... state – including the Ohio Third Frontier - and ... been raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... 2015 Innovation is more urgent ... unexpected parts of the world and transforming global ... to manufacturing to health care, disruption is constantly ... and socio-political trends shake the foundations of established ... for CEOs to survive the next wave of ...
(Date:2/26/2015)... JUPITER, Fla. , Feb. 26, 2015 /PRNewswire/ ... biotechnology company whose patented and proprietary technologies are ... other proteins for the bioenergy, bio-based chemical, biopharmaceutical ... will report its financial results for year ending ... March 11, 2015 and will host a conference ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3
... ,The dial-in code is: 3684539 To view ... Upcoming Financial Date: February 2012 ... 2011 This press release contains statements about ... of these statements cannot be guaranteed as they are ...
... Oncology announces completion of a phase I Small Business ... Cancer Institute (NCI).  The SBIR grant project ... (JIT) to enroll cancer patients into clinical trials. ... with qualifying diagnoses across many research practices. Patients who ...
... Oct. 20, 2011 Med track is pleased ... 2011. Attendees of the show will be the first ... the newly designed platform. With deeply integrated datasets and ... professionals in business development, competitive intelligence and sales and ...
Cached Biology Technology:Nine-Month Figures for 2011: Dynamic, Profitable Growth at Sartorius 2Pharmatech Oncology Announces Completion of SBIR Grant Research 2Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011 2
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... --  Epic Sciences , a precision diagnostics company dedicated to ... Prahalad , Ph.D., president and CEO, is scheduled to present ... Silicon Valley, which is taking place at the Computer History ... January 26-28, 2015. Dr. Prahalad will give ... year, Epic Sciences was a finalist in the PMWC,s Most ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... Today, researchers report for the first time ... are inherited only from the motherare directly linked to ... which highlights the role of mitochondrial genome variation in ... Genome Research ( www.genome.org ). According ...
... may affect school attendance, researchers at the University of ... are at greater risk of school absenteeism than their ... thousand 4th, 5th and 6th graders in the Philadelphia ... BMI, is as significant a factor in determining absenteeism ...
... arent so much in the genes we have, which are 99 ... according to new research from a Duke University team. ... very different ways. In two major traits that set humans ... diet gene regulation, the complex cross-talk that governs when genes ...
Cached Biology News:Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes 2Childhood obesity indicates greater risk of school absenteeism, Penn study reveals 2Gene regulation, not just genes, is what sets humans apart 2Gene regulation, not just genes, is what sets humans apart 3
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
SHEEP ANTI BOVINE LACTOPEROXIDASE...
... utility and flexibility press-to-seal silicone isolators can ... the researcher. They are available either pre-cut ... material that can be easily trimmed to ... and non-cytotoxic and can be used to ...
Request Info...
Biology Products: